These Stocks Are Moving the Most Today: Tesla, Trump Media, Coinbase, Robinhood, Autolus, and More -- Barrons.com

Dow Jones11-11

By Joe Woelfel

Stock futures were rising Monday after Wall Street closed out its best week of the year, with the S&P 500 rising 4.7% and the Dow Jones Industrial Average finishing with a gain of 4.6%.

These stocks were poised to make moves Monday:

Tesla jumped 7.2% in premarket trading after the electric-vehicle maker closed Friday with a market cap above $1 trillion for the first time since April 25, 2022, according to Dow Jones Market Data. The stock rose 29% last week for its best weekly performance since late January 2023. The stock rose 15% alone last Wednesday, the day after Donald Trump was elected U.S. president. Elon Musk, Tesla CEO, actively campaigned for Trump, spending millions of dollars to support Trump's bid.

Trump Media & Technology Group rose 6.1% after a topsy-turvy week for the company that operates the Truth Social social-media platform and which is roughly 57%-owned by President-elect Trump. The stock fell 23% on Thursday but closed with a gain of 15% on Friday after Trump said he has no intention of selling his shares in Trump Media.

Coinbase Global surged 17%, MicroStrategy was up 12%, Robinhood Markets rose 11%, and other cryptocurrency-related stocks gained momentum as Bitcoin traded above $82,000. The largest crypto passed $80,000 for the first time ever on Sunday. Digital assets have soared on expectations that a second Trump presidency would be crypto-friendly. The president-elect has said he'd make the U.S. "the crypto capital world."

Earnings reports are expected Monday from Live Nation Entertainment, Monday.com, and Grab Holdings.

Reports are expected later in the week from Home Depot, Shopify, Spotify Technology, Occidental Petroleum, Cisco Systems, Walt Disney, Applied Materials, Alibaba, JD.com, and Talen Energy.

Autolus Therapeutics rose 17% after it received Food and Drug Administration approval of Aucatzyl, the London biopharmaceutical company's treatment of acute lymphoblastic leukemia, or ALL, an aggressive blood and bone marrow cancer, for certain patients.

Write to Joe Woelfel at joseph.woelfel@barrons.com

This content was created by Barron's, which is operated by Dow Jones & Co. Barron's is published independently from Dow Jones Newswires and The Wall Street Journal.

 

(END) Dow Jones Newswires

November 11, 2024 05:47 ET (10:47 GMT)

Copyright (c) 2024 Dow Jones & Company, Inc.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment